
HLS on TSX | Today's Change | Volume | 52 Week Range (Low/Hi) | Market Cap |
18.57CAN | 1.36% | 33,594 | 13.35 - 21.89 | 589.484M |
Contact Information
HLS Therapeutics Inc.
Headquarters:10 Carlson Court, Suite 701
Etobicoke, Ontario
Canada, M9W 6L2
Tel: 1-647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website
For more information...
Lead: Scott LoganMar 19, 2021 - 11:00 AM EDT |
Corporate Presentation - Toronto |
HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.
HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania). We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.
Bill Wells, BA, MBA - Executive Chairman of the Board
Gilbert Godin , BEng, MBA - Chief Executive Officer
Tim Hendrickson, MBA - Chief Financial Officer
Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development
Ryan C. Lennox BA, JD - General Counsel
Sanjiv Sharma, MBA - Chief Commercial Officer
Jason A. Gross, PharmD - VP Scientific Affairs
Bill Wells, BA, MBA - Executive Chairman of the Board
Gilbert Godin , BEng, MBA - Chief Executive Officer
Greg Gubitz, BA, LLB - Director
J. Spencer Lanthier - Director, Independent
Yvon Bastien - Director, Independent
Laura A. Brege - Director, Independent
Don DeGolyer - Director, Independent
Rodney Hill - Director, Independent

Stock Information
Events
Mar 19, 2021 - 11:00 AM EDT |
Corporate Presentation - Toronto |
Press Releases
Company Overview
HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.
HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania). We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.
Management
Bill Wells, BA, MBA - Executive Chairman of the Board
Gilbert Godin , BEng, MBA - Chief Executive Officer
Tim Hendrickson, MBA - Chief Financial Officer
Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development
Ryan C. Lennox BA, JD - General Counsel
Sanjiv Sharma, MBA - Chief Commercial Officer
Jason A. Gross, PharmD - VP Scientific Affairs
Board of Directors
Bill Wells, BA, MBA - Executive Chairman of the Board
Gilbert Godin , BEng, MBA - Chief Executive Officer
Greg Gubitz, BA, LLB - Director
J. Spencer Lanthier - Director, Independent
Yvon Bastien - Director, Independent
Laura A. Brege - Director, Independent
Don DeGolyer - Director, Independent
Rodney Hill - Director, Independent
Contact Information
10 Carlson Court, Suite 701
Etobicoke, Ontario
M9W 6L2, Canada
Telephone: 1-647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website